Patient data in healthcare is very personal and sensitive. It includes medical histories, diagnoses, genetic information, lifestyle details, and more. AI applications often need large sets of data to train computer programs to do jobs like diagnosing diseases from medical images, predicting patient risks, or managing appointments.
For example, the FDA has approved AI systems for diagnostic use, such as detecting diabetic retinopathy accurately. Google’s DeepMind Health worked with the NHS in London to find acute kidney injuries using patient data. In the United States, AI tools look at X-rays, genetic profiles, and electronic health records (EHRs) to help doctors.
Still, collecting and using this much health information creates a big challenge: making sure patient privacy is not broken. A 2018 survey in the U.S. showed that only 11% of Americans feel okay sharing their health data with tech companies, while 72% trust doctors more. This shows there are worries about data security and who controls the data when private companies handle health information.
Many AI tools in healthcare are made or managed by private companies. While working with these companies can help improve patient care, it also brings risks about who owns and uses the data.
Private companies may want data not only for medical reasons but also for research, developing products, or making money. This can cause data to be accessed or used without proper permission, especially if patients didn’t clearly agree to all uses of their data.
A well-known case is the partnership between Google’s DeepMind and the Royal Free London NHS Foundation Trust. An investigation found patient data was accessed on an “inappropriate legal basis,” which caused public and government concern. This happened in the UK but shows problems U.S. healthcare groups can face when working with tech vendors or third-party AI tools.
Without clear rules and agreements, patient data might be shared or moved between places with different privacy laws. This makes it harder to monitor and increases risks.
One way to protect patient privacy is to “anonymize” data before using it in AI training. This means removing names, addresses, or birthdates. However, new AI and data analysis methods can sometimes find out who the data belongs to by linking it with other data sources.
Some studies showed up to 85.6% of adults could be identified again from anonymized fitness data. Nearly 70% of children’s anonymized data was also re-identified in some research. This breaks the usual privacy protections and means stronger methods are needed.
New approaches include using AI models to create fake patient data. This fake data looks like real data but does not connect back to any real person. While this idea shows promise, it still needs more testing and approval before it can be used safely in healthcare.
Many AI systems, especially those using deep learning, work like “black boxes.” Their decision process is hidden, even from the people who made or use them.
This makes it hard to check how patient data is used or how the AI makes decisions. For healthcare managers in charge of following rules and handling risks, this lack of transparency is a problem.
Also, hidden AI methods can hide mistakes or bias in the data used to train them. Without clear explanations, patients and doctors cannot fully understand how their health information affects AI suggestions.
Current U.S. health privacy laws, like HIPAA, offer important protections for patient data. But HIPAA was made before AI grew fast, so some rules do not cover AI well.
The FDA has started approving AI medical tools, but the rules need to grow to handle ongoing data use and updates in AI systems.
Public and private groups working on AI in healthcare also need clearer laws about who is responsible, who owns the data, and how patient permission is managed. Without these updates, patients may face privacy risks and possible legal problems.
Whether patients are willing to share health data depends on whom they trust to handle it. The 2018 U.S. survey showed most people trust their doctors more than tech companies.
Trust is also damaged by cases where data was misused or shared without permission. Examples include DeepMind’s work with the NHS and data breaches at U.S. hospitals involving big tech firms.
Informed consent is very important. Patients must understand and agree to how their data is used. Since AI can change over time, consent should be updated regularly. Patients should also be able to take back permission if they want.
AI is also used in healthcare administration like answering calls, scheduling appointments, handling patient questions, and entering data. These jobs were often done by reception staff before.
In U.S. medical offices, automation can make work faster, cut wait times, and let staff focus more on patients. But automating front-office tasks means handling sensitive health data during calls or messages.
For example, a company called Simbo AI uses 256-bit AES encryption to protect data and follow HIPAA rules when automating phone tasks. This strong encryption keeps patient info safe during AI use.
Data security steps that apply to clinical AI tools should also be used for administrative AI:
Automated workflows often link with Electronic Health Records and practice systems. This helps data flow smoothly, but can cause worries about data being split up or privacy risks if different systems don’t work well or are not all secure.
Also, using voice-based AI assistants to talk with patients means keeping audio data private throughout its use. AI makers must meet strict rules to earn trust from healthcare workers and patients.
Because of these privacy problems, healthcare leaders and IT staff should use these methods to keep AI safe:
The rules around healthcare AI data privacy are changing:
Healthcare managers must keep up with these changes and update privacy rules and contracts to stay legal and keep patient trust.
Healthcare managers, owners, and IT staff in U.S. medical settings must handle AI tools that can make care better and work faster without risking patient privacy.
Their main duties include:
Healthcare professionals must balance the good parts of AI with the duty to protect patient data. This means using better technology, knowing legal rules, talking clearly with patients, and keeping a close watch on AI use in the changing healthcare world.
The key concerns include the access, use, and control of patient data by private entities, potential privacy breaches from algorithmic systems, and the risk of reidentifying anonymized patient data.
AI technologies are prone to specific errors and biases and often operate as ‘black boxes,’ making it challenging for healthcare professionals to supervise their decision-making processes.
The ‘black box’ problem refers to the opacity of AI algorithms, where their internal workings and reasoning for conclusions are not easily understood by human observers.
Private companies may prioritize profit over patient privacy, potentially compromising data security and increasing the risk of unauthorized access and privacy breaches.
To effectively govern AI, regulatory frameworks must be dynamic, addressing the rapid advancements of technologies while ensuring patient agency, consent, and robust data protection measures.
Public-private partnerships can facilitate the development and deployment of AI technologies, but they raise concerns about patient consent, data control, and privacy protections.
Implementing stringent data protection regulations, ensuring informed consent for data usage, and employing advanced anonymization techniques are essential steps to safeguard patient data.
Emerging AI techniques have demonstrated the ability to reidentify individuals from supposedly anonymized datasets, raising significant concerns about the effectiveness of current data protection measures.
Generative data involves creating realistic but synthetic patient data that does not connect to real individuals, reducing the reliance on actual patient data and mitigating privacy risks.
Public trust issues stem from concerns regarding privacy breaches, past violations of patient data rights by corporations, and a general apprehension about sharing sensitive health information with tech companies.